Heart Failure Clinical Trial
A Comparison of Magnetic Resonance Imaging in Persons With Heart Failure to Health, Aged Matched Controls
Summary
The purpose of this study is to examine the relation between the structural brain changes associated with heart failure, neurocognitive performance, and how these changes impact self-care behaviors.
Full Description
The purpose of this study is use neuroimaging techniques to better understand the underlying structural brain changes and physiological mechanisms that guide the thinking and decision making processes required for people with heart failure. The study will compare how the underlying brain structures and circulation are similar to or different in persons with heart failure to healthy, aged matched controls using special neuroimaging procedures.
Eligibility Criteria
Inclusion Criteria:
Participants with heart failure:
Speak and understand English
Live independently within a 60 mile radius of Atlanta
Montreal Cognitive Assessment (MOCA) score of less than or equal to 24
Documented medical diagnosis of New York Heart Association (NYHA) class II or III systolic
Left ventricular ejection fraction (LVEF) greater than or equal to 10% that is documented within the last year by echocardiogram, cardiac catheterization ventriculography, or radionuclide ventriculography
Receiving medication therapy for heart failure (HF) according to American College of Cardiology (ACC) American Heart recommendation guidelines for at least 8 weeks prior to study enrollment
Healthy Controls
Speak and understand English
Live independently within a 60 mile radius of Atlanta
Exclusion Criteria:
Participants with heart failure:
New York Heart Association (NYHA) class I or IV
Change in heart failure (HF) therapy within 6 months
Worsening of heart failure (HF) symptoms within last 5 days
Unstable angina
Renal insufficiency (serum creatinine greater than 3.o mg/dL)
Hospitalized within the last 30-days
Diagnosed with any neurological disorder that may interfere with cognitive function
Beck Depression Inventory II (BDI-II) score greater than 25
Claustrophobia
Implanted devices such as internal cardiac defibrillator or pacemaker
Carrying non-removable objects
Stents
Body weight more than 120 kg
Healthy Controls
Taking prescription medications
Cardiovascular disease;
Cerebrovascular disease
Neurological disease
Respiratory disease
Claustrophobia
Any implanted metal objects not considered safe or appropriate for the MRI environment.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 3 Locations for this study
Atlanta Georgia, 30308, United States
Atlanta Georgia, 30322, United States
Atlanta Georgia, 30342, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.